When to Use Anthracyclines in Early Breast Cancer

Post hoc data from TAILORx show that adding an anthracycline to taxane-based chemotherapy benefits patients with HR-positive early breast cancer who have recurrence scores of 31 or higher.
Medscape Medical News
Post hoc data from TAILORx show that adding an anthracycline to taxane-based chemotherapy benefits patients with HR-positive early breast cancer who have recurrence scores of 31 or higher.
Medscape Medical News